Question 1

What is CURA and what does it do?

Accepted Answer

CURA is an enterprise-grade healthcare intelligence platform that delivers real-time regulatory intelligence, pharmaceutical pipeline tracking, biomedical device intelligence, and healthcare analytics across 75+ global jurisdictions. Our AI-powered platform captures and parses regulatory documents within minutes of publication, transforming complex legal and technical content into clear, actionable intelligence. We serve pharmaceutical companies, medical device manufacturers, healthcare providers, institutional investors, consulting firms, and research organizations that require timely, accurate healthcare market intelligence.

Question 2

How does CURA differ from traditional healthcare market research firms?

Accepted Answer

Traditional research firms typically deliver periodic reports on monthly, quarterly, or annual cycles based on manual research processes. CURA provides continuous, real-time intelligence through 1,420+ active monitoring pipelines that capture regulatory updates within minutes of official publication. Our AI parsing engine processes documents automatically without human delay, and our analytics platform enables self-service exploration of intelligence data rather than reliance on pre-packaged reports with fixed structures.

Question 3

Is CURA a cloud-based software platform?

Accepted Answer

Yes. CURA is a cloud-native SaaS platform accessible through any modern web browser and optimized for mobile-responsive access. Enterprise clients can also access platform data through our RESTful API for integration with on-premises business intelligence systems, data warehouses, and workflow tools.

Question 4

How secure is the CURA platform?

Accepted Answer

CURA maintains enterprise-grade security including SOC 2 Type II attestation, encrypted data transmission (TLS 1.3) and storage (AES-256), granular role-based access controls, comprehensive audit logging of all user activities, and regular third-party penetration testing. We maintain strict compliance with applicable data protection regulations.

Question 5

What regulatory bodies does CURA monitor?

Accepted Answer

We continuously monitor 50+ regulatory bodies across 75+ jurisdictions, including comprehensive coverage of FDA (all centers), EMA (including CHMP, PRAC, CAT committees), PMDA (Japan), NMPA (China), Health Canada, TGA (Australia), MHRA (UK post-Brexit), MFDS (South Korea), ANVISA (Brazil), and 40+ additional national and regional regulatory authorities.

Question 6

How many drug and device records does CURA track?

Accepted Answer

Our database includes 25,000+ drug pipeline records spanning all therapeutic areas and development phases, and 15,000+ medical device approval records with detailed regulatory attributes. Both datasets are updated continuously as new products enter development and new approvals are granted.

Question 7

How quickly is data updated after regulatory publication?

Accepted Answer

Regulatory updates are typically captured and parsed within 5-15 minutes of official publication. Monthly scheduled updates, such as PMDA approval updates, are processed within 24 hours of publication. Clinical trial registries are refreshed weekly, and company earnings data is captured in real time during earnings seasons.

Question 8

Does CURA provide historical data or only current information?

Accepted Answer

CURA maintains extensive historical archives with comprehensive coverage extending back 10+ years for major markets including the US, EU, and Japan. Historical data includes regulatory documents, approval records, clinical trial registrations, patent filings, and market developments. Historical depth varies by data type and jurisdiction.

Question 9

What pharmaceutical intelligence capabilities does CURA provide?

Accepted Answer

Our pharmaceutical intelligence includes drug pipeline tracking (25,000+ records across all therapeutic areas), clinical trial monitoring with enrollment and outcome tracking, regulatory submission analysis across FDA, EMA, PMDA and other major bodies, patent landscape and exclusivity analysis, competitive intelligence, and market access data. We cover all therapeutic areas from preclinical discovery through commercial lifecycle management.

Question 10

What device intelligence capabilities are available?

Accepted Answer

Our biomedical device intelligence includes FDA 510(k), PMA, and De Novo clearance tracking, European MDR and IVDR transition monitoring with notified body capacity data, therapy area-specific device intelligence for cardiology, neurology, orthopedics, and surgery, competitive device portfolio mapping and benchmarking, and reimbursement and coding intelligence including CPT and HCPCS tracking.

Question 11

Does CURA track software as a medical device (SaMD) and AI-enabled devices?

Accepted Answer

Yes, we specifically track SaMD approvals, AI/ML-based device clearances under FDA’s predetermined change control plan framework, digital therapeutics, and the rapidly evolving regulatory frameworks for software-enabled and algorithm-based medical devices across all major markets.

Question 12

Can I track specific competitors or product categories?

Accepted Answer

Yes. Our competitive intelligence module allows you to create unlimited competitor watchlists, track specific company pipelines and portfolios, monitor defined product categories or therapeutic areas, and receive customized alerts when competitors achieve regulatory milestones, publish clinical data, or make strategic announcements.

Question 13

What analytics capabilities does the CURA platform offer?

Accepted Answer

CURA provides customizable real-time dashboards, automated report generation with scheduling and distribution, AI-powered trend analysis and pattern recognition, predictive modeling for approval timeline forecasting, and competitive benchmarking analytics. All analytics can be configured by geography, therapy area, competitor set, regulatory body, and custom criteria.

Question 14

Can I export data or integrate CURA with other business intelligence tools?

Accepted Answer

Yes. CURA supports data export in CSV, Excel, JSON, and PDF formats. Our RESTful API enables direct integration with Tableau, Microsoft Power BI, and other major BI platforms. We offer pre-built connectors for common enterprise tools with detailed documentation and implementation support.

Question 15

How customizable are the alerts and notifications?

Accepted Answer

Alerts are fully customizable with sophisticated rule configuration. Set criteria by regulatory body, document type, therapeutic area, specific competitor names, keywords, device classification, or any combination using Boolean logic. Delivery options include email, SMS, Slack, Microsoft Teams, and API webhook for system integration.

Question 16

How is CURA priced?

Accepted Answer

We offer tiered subscription plans to serve organizations of all sizes. Professional tier is designed for individual users with core platform access. Team tier adds multi-user collaboration, advanced analytics, and API access. Enterprise tier provides unlimited users, custom integrations, SLA guarantees, and dedicated support. Module-specific licensing is also available for organizations with focused needs.

Question 17

Is there a free trial or evaluation period available?

Accepted Answer

We offer limited-access trial accounts for qualified organizations following a brief discovery conversation to understand your needs and configure relevant data feeds. Contact our team to discuss trial eligibility, scope, and duration.

Question 18

Can I purchase access to only specific modules or solutions?

Accepted Answer

Yes. While many clients subscribe to the full integrated platform, module-specific licensing is available for organizations with focused needs — for example, Device Tracker only for medtech companies, or Regulatory Approvals Guide only for regulatory affairs teams.

Question 19

What technical support options are available?

Accepted Answer

Standard support is included with all subscriptions via email and secure chat during US business hours. Enterprise clients receive priority phone support with guaranteed response times, dedicated account management, and 24/7 emergency support for critical issues.

Question 20

How do I get started with CURA?

Accepted Answer

The typical process begins with a discovery call to understand your intelligence requirements, followed by a tailored platform demonstration. Upon subscription, our implementation team guides onboarding including platform configuration, user setup, alert customization, and training. Most clients are fully operational within two weeks.

Question 21

Can CURA support global teams across multiple time zones?

Accepted Answer

Yes. Our platform supports multi-language interface options, timezone-aware scheduling and alerting, and region-specific data views. Enterprise deployments can be configured with global team structures, localized data access permissions, and regional administrator roles.

Question 22

How do I request a new feature or report a technical issue?

Accepted Answer

Feature requests and technical issues can be submitted through the platform’s integrated feedback system, via email to support@cura-intel.com, or through your dedicated account manager for Enterprise clients. We review all requests quarterly and prioritize based on client demand and strategic alignment.

Welcome to CURA

Are you an HCP or a manufacturer?

HCP (Healthcare Professional)

Manufacturer

Frequently Asked Questions About Healthcare Intelligence

Have any additional custom questions?